Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Eledon Pharmaceuticals stock

Own Eledon Pharmaceuticals stock in just a few minutes.

Eledon Pharmaceuticals, Inc is a biotechnology business based in the US. Eledon Pharmaceuticals shares (NVUS) are listed on the NASDAQ and all prices are listed in US Dollars. Eledon Pharmaceuticals employs 7 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Eledon Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – NVUS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Eledon Pharmaceuticals share price

Use our graph to track the performance of NVUS stocks over time.

Eledon Pharmaceuticals shares at a glance

Information last updated 2021-03-08.
52-week range$4.50 - $26.44
50-day moving average $15.71
200-day moving average $15.63
Wall St. target price$35.00
PE ratio 2.0936
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.70

Buy Eledon Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Eledon Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Eledon Pharmaceuticals under- or over-valued?

Valuing Eledon Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Eledon Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Eledon Pharmaceuticals's P/E ratio

Eledon Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 2x. In other words, Eledon Pharmaceuticals shares trade at around 2x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Eledon Pharmaceuticals's PEG ratio

Eledon Pharmaceuticals's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.01. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Eledon Pharmaceuticals's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Eledon Pharmaceuticals financials

Gross profit TTM $0
Return on assets TTM -7.29%
Return on equity TTM -21.07%
Profit margin 0%
Book value $16.87
Market capitalisation $21 million

TTM: trailing 12 months

Shorting Eledon Pharmaceuticals shares

There are currently 108,935 Eledon Pharmaceuticals shares held short by investors – that's known as Eledon Pharmaceuticals's "short interest". This figure is 7.3% down from 117,523 last month.

There are a few different ways that this level of interest in shorting Eledon Pharmaceuticals shares can be evaluated.

Eledon Pharmaceuticals's "short interest ratio" (SIR)

Eledon Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Eledon Pharmaceuticals shares currently shorted divided by the average quantity of Eledon Pharmaceuticals shares traded daily (recently around 21962.701612903). Eledon Pharmaceuticals's SIR currently stands at 4.96. In other words for every 100,000 Eledon Pharmaceuticals shares traded daily on the market, roughly 4960 shares are currently held short.

However Eledon Pharmaceuticals's short interest can also be evaluated against the total number of Eledon Pharmaceuticals shares, or, against the total number of tradable Eledon Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Eledon Pharmaceuticals's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Eledon Pharmaceuticals shares in existence, roughly 80 shares are currently held short) or 0.1024% of the tradable shares (for every 100,000 tradable Eledon Pharmaceuticals shares, roughly 102 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Eledon Pharmaceuticals.

Find out more about how you can short Eledon Pharmaceuticals stock.

Eledon Pharmaceuticals share dividends

We're not expecting Eledon Pharmaceuticals to pay a dividend over the next 12 months.

Have Eledon Pharmaceuticals's shares ever split?

Eledon Pharmaceuticals's shares were split on a 1:18 basis on 4 October 2020. So if you had owned 18 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Eledon Pharmaceuticals shares – just the quantity. However, indirectly, the new 1700% higher share price could have impacted the market appetite for Eledon Pharmaceuticals shares which in turn could have impacted Eledon Pharmaceuticals's share price.

Eledon Pharmaceuticals share price volatility

Over the last 12 months, Eledon Pharmaceuticals's shares have ranged in value from as little as $4.5 up to $26.44. A popular way to gauge a stock's volatility is its "beta".

NVUS.US volatility(beta: 2.31)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Eledon Pharmaceuticals's is 2.3075. This would suggest that Eledon Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Eledon Pharmaceuticals overview

Eledon Pharmaceuticals, Inc. , a specialty pharmaceutical company, focuses on developing products for patients with disorders of ear, nose, and throat. The company's lead product is OP0201, a surfactant-based nasal aerosol drug-device combination product for patients at risk for, or with, otitis media (OM) (middle ear inflammation with or without infection). It also has a foam-based drug delivery technology OP0101 and OP0102 that could be used to deliver drugs into the ear, nose, and sinus cavities. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021.

Frequently asked questions

What percentage of Eledon Pharmaceuticals is owned by insiders or institutions?
Currently 0.174% of Eledon Pharmaceuticals shares are held by insiders and 13.127% by institutions.
How many people work for Eledon Pharmaceuticals?
Latest data suggests 7 work at Eledon Pharmaceuticals.
When does the fiscal year end for Eledon Pharmaceuticals?
Eledon Pharmaceuticals's fiscal year ends in December.
Where is Eledon Pharmaceuticals based?
Eledon Pharmaceuticals's address is: 19900 MacArthur Boulevard, Irvine, CA, United States, 92612
What is Eledon Pharmaceuticals's ISIN number?
Eledon Pharmaceuticals's international securities identification number is: US67011N2045
What is Eledon Pharmaceuticals's CUSIP number?
Eledon Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 67011N105

More guides on Finder

  • How to buy Bitpanda Ecosystem Token (BEST)

    This guide will show you step-by-step instructions on how to buy the Bitpanda Ecosystem Token (BEST) as well as a list of exchanges you can trade it on.

  • How to buy Thorecoin (THR)

    This guide will show you step-by-step instructions on how to buy the Thorecoin (THR) token as well as a list of exchanges you can trade it on.

  • How to buy Whitecoin (XWC)

    This guide will show you step-by-step instructions on how to buy the Whitecoin (XWC) token as well as a list of exchanges you can trade it on.

  • How to buy Ino Coin (INO)

    This guide will show you step-by-step instructions on how to buy the Ino Coin (INO) token as well as a list of exchanges you can trade it on.

  • How to buy ECOMI (OMI)

    This guide will show you step-by-step instructions on how to buy the ECOMI (OMI) token as well as a list of exchanges you can trade it on.

  • How to buy DeFiChain (DFI)

    This guide will show you step-by-step instructions on how to buy the DeFiChain (DFI) token as well as a list of exchanges you can trade it on.

  • How to buy Huobi BTC (HBTC)

    This guide will show you step-by-step instructions on how to buy the Huobi BTC (HBTC) token as well as a list of exchanges you can trade it on.

  • How to buy Fei Protocol (FEI)

    This guide will show you step-by-step instructions on how to buy the Fei Protocol (FEI) token as well as a list of exchanges you can trade it on.

  • How to buy CounosX (CCXX)

    This guide will show you step-by-step instructions on how to buy the CounosX (CCXX) token as well as a list of exchanges you can trade it on.

  • How to buy Wrapped BNB (WBNB)

    This guide will show you step-by-step instructions on how to buy the Wrapped BNB (WBNB) token as well as a list of exchanges you can trade it on.

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site